Clopidogrel pharmacokinetics and pharmacodynamics vary widely despite exclusion or control of polymorphisms (CYP2C19, ABCB1, PON1), noncompliance, diet, smoking, co-medications (including proton pump inhibitors), and pre-existent variability in platelet function.
J Am Coll Cardiol
; 61(8): 872-9, 2013 Feb 26.
Article
en En
| MEDLINE
| ID: mdl-23333143
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Polimorfismo Genético
/
Ticlopidina
/
Enfermedades Cardiovasculares
/
Agregación Plaquetaria
/
2-Piridinilmetilsulfinilbencimidazoles
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
Idioma:
En
Año:
2013
Tipo del documento:
Article